PRIVERZhENNOST' K LEChENIYu OSTEOPOROZA: VOPROSPERENOSIMOSTI, REZhIMA LEChENIYaILI ISKLYuChITEL'NO KhOROShEGO DIALOGA S PATsIENTOM?
Good antifracture treatment efficacy requires adherence, which is often suboptimal. The most common reason for nonadherence is real or perceived intolerance to the medication. Although dosage frequency plays a significant role, pharmacokinetics is but one of many barriers to adherence. Patient-relat...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Endocrinology Research Centre
2010-12-01
|
| Series: | Остеопороз и остеопатии |
| Online Access: | https://endojournals.ru/index.php/osteo/article/view/4196 |